Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raynier Devillier

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Bone Marrow Transplantation|June 27, 2026
Fludarabine, cyclophosphamide and 2 Gy TBI with PT-Cy as a single platform for haplo and unrelated donor allo-SCT in older AML or MDS patientsGuillaume Berton, Sabine Fürst, Benjamin Bouchacourt, et al.
Bone Marrow Transplantation|November 4, 2023
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndromeSamia Harbi, Louison Brac de la Perriere, Benjamin Bouchacourt, et al.
Transplantation and Cellular Therapy|December 26, 2021
Risk Factors for Early Cytomegalovirus Reactivation and Impact of Early Cytomegalovirus Reactivation on Clinical Outcomes after T Cell-Replete Haploidentical Transplantation with Post-Transplantation CyclophosphamideJacopo Mariotti, Faezeh Legrand, Sabine Furst, et al.
Bone Marrow Transplantation|June 29, 2026
T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMTSarah Kayser, Arnon Nagler, Allain Thibeault Ferhat, et al.
Bone Marrow Transplantation|November 16, 2020
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcomeLuca Castagna, Thomas Pagliardini, Stefania Bramanti, et al.
Haematologica|April 9, 2016
Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working PartyRaynier Devillier, Jean-Hugues Dalle, Austin Kulasekararaj, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 26, 2019
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 PatientsThomas Pagliardini, Lucas Castagna, Samia Harbi, et al.
European Journal of Haematology|August 12, 2024
Venetoclax-based non-intensive induction followed by allogenic stem-cell transplantation in elderly acute myeloid leukemia patients with adverse cytogeneticsAmel Soua, Julia Gilhodes, Alexandre Iat, et al.
Nature Communications|June 30, 2022
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editingSumin Jo, Shipra Das, Alan Williams, et al.
American Journal of Hematology|May 23, 2024
Peripheral blood stem cell versus bone marrow graft for patients ≥60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationRaynier Devillier, Jacques-Emmanuel Galimard, Didier Blaise, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Bone Marrow Transplantation|June 27, 2026
Fludarabine, cyclophosphamide and 2 Gy TBI with PT-Cy as a single platform for haplo and unrelated donor allo-SCT in older AML or MDS patientsGuillaume Berton, Sabine Fürst, Benjamin Bouchacourt, et al.
Bone Marrow Transplantation|November 4, 2023
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndromeSamia Harbi, Louison Brac de la Perriere, Benjamin Bouchacourt, et al.
Transplantation and Cellular Therapy|December 26, 2021
Risk Factors for Early Cytomegalovirus Reactivation and Impact of Early Cytomegalovirus Reactivation on Clinical Outcomes after T Cell-Replete Haploidentical Transplantation with Post-Transplantation CyclophosphamideJacopo Mariotti, Faezeh Legrand, Sabine Furst, et al.
Bone Marrow Transplantation|June 29, 2026
T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMTSarah Kayser, Arnon Nagler, Allain Thibeault Ferhat, et al.
Bone Marrow Transplantation|November 16, 2020
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcomeLuca Castagna, Thomas Pagliardini, Stefania Bramanti, et al.
Haematologica|April 9, 2016
Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working PartyRaynier Devillier, Jean-Hugues Dalle, Austin Kulasekararaj, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 26, 2019
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 PatientsThomas Pagliardini, Lucas Castagna, Samia Harbi, et al.
European Journal of Haematology|August 12, 2024
Venetoclax-based non-intensive induction followed by allogenic stem-cell transplantation in elderly acute myeloid leukemia patients with adverse cytogeneticsAmel Soua, Julia Gilhodes, Alexandre Iat, et al.
Nature Communications|June 30, 2022
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editingSumin Jo, Shipra Das, Alan Williams, et al.
American Journal of Hematology|May 23, 2024
Peripheral blood stem cell versus bone marrow graft for patients ≥60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationRaynier Devillier, Jacques-Emmanuel Galimard, Didier Blaise, et al.
Pageof 9